357 related articles for article (PubMed ID: 20863909)
1. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.
Wei J; Bhattacharyya S; Tourtellotte WG; Varga J
Autoimmun Rev; 2011 Mar; 10(5):267-75. PubMed ID: 20863909
[TBL] [Abstract][Full Text] [Related]
2. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.
Bhattacharyya S; Wei J; Varga J
Nat Rev Rheumatol; 2011 Oct; 8(1):42-54. PubMed ID: 22025123
[TBL] [Abstract][Full Text] [Related]
3. PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.
Wei J; Ghosh AK; Sargent JL; Komura K; Wu M; Huang QQ; Jain M; Whitfield ML; Feghali-Bostwick C; Varga J
PLoS One; 2010 Nov; 5(11):e13778. PubMed ID: 21072170
[TBL] [Abstract][Full Text] [Related]
4. β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.
Beyer C; Schramm A; Akhmetshina A; Dees C; Kireva T; Gelse K; Sonnylal S; de Crombrugghe B; Taketo MM; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 May; 71(5):761-7. PubMed ID: 22328737
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome.
Lemaire R; Farina G; Bayle J; Dimarzio M; Pendergrass SA; Milano A; Perbal B; Whitfield ML; Lafyatis R
J Invest Dermatol; 2010 Jun; 130(6):1514-23. PubMed ID: 20182440
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis in systemic sclerosis: common and unique pathobiology.
Bhattacharyya S; Wei J; Tourtellotte WG; Hinchcliff M; Gottardi CG; Varga J
Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S18. PubMed ID: 23259815
[TBL] [Abstract][Full Text] [Related]
7. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
Lemaire R; Bayle J; Lafyatis R
Curr Opin Rheumatol; 2006 Nov; 18(6):582-7. PubMed ID: 17053502
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways as novel therapeutic targets in systemic sclerosis.
Trojanowska M; Varga J
Curr Opin Rheumatol; 2007 Nov; 19(6):568-73. PubMed ID: 17917537
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.
Wei J; Fang F; Lam AP; Sargent JL; Hamburg E; Hinchcliff ME; Gottardi CJ; Atit R; Whitfield ML; Varga J
Arthritis Rheum; 2012 Aug; 64(8):2734-45. PubMed ID: 22328118
[TBL] [Abstract][Full Text] [Related]
10. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
11. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation.
Kissin EY; Lemaire R; Korn JH; Lafyatis R
Arthritis Rheum; 2002 Nov; 46(11):3000-9. PubMed ID: 12428243
[TBL] [Abstract][Full Text] [Related]
13. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.
Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J
Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446
[TBL] [Abstract][Full Text] [Related]
14. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
[TBL] [Abstract][Full Text] [Related]
15. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator.
Bhattacharyya S; Wang W; Graham LV; Varga J
Arthritis Res Ther; 2016 Oct; 18(1):216. PubMed ID: 27716397
[TBL] [Abstract][Full Text] [Related]
16. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
[TBL] [Abstract][Full Text] [Related]
18. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.
Gerber EE; Gallo EM; Fontana SC; Davis EC; Wigley FM; Huso DL; Dietz HC
Nature; 2013 Nov; 503(7474):126-30. PubMed ID: 24107997
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis.
Korman B; Marangoni RG; Lord G; Olefsky J; Tourtellotte W; Varga J
Arthritis Res Ther; 2018 Jul; 20(1):145. PubMed ID: 29996896
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype".
Zhou X; Tan FK; Milewicz DM; Guo X; Bona CA; Arnett FC
J Immunol; 2005 Oct; 175(7):4555-60. PubMed ID: 16177099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
